Breaking

Google Rolls Out Android 17 with New Features and Pixel Drop Rivian Lays Off Hundreds of Workers Amid Restructuring Efforts Consumers Skeptical of AI, Value Human Authorship Over AI Citations Snap Launches Augmented Reality Glasses 'Specs' for $2,195 Ivanka Trump and Jared Kushner's Albania Resort Plan Sparks Protests and Environmental Concerns 15 Charged in Minnesota for Impeding Federal Agents During Immigration Surge US Education Department's Civil Rights and Special Education Offices to Relocate Mobileye Plans 2027 Robotaxi Service Launch in U.S. City Qualcomm Unveils Snapdragon Reality Elite Chip for Augmented Reality Devices Apple's Future Hardware Rumors: Camera AirPods, Foldable Phones, and New iPhones Google Rolls Out Android 17 with New Features and Pixel Drop Rivian Lays Off Hundreds of Workers Amid Restructuring Efforts Consumers Skeptical of AI, Value Human Authorship Over AI Citations Snap Launches Augmented Reality Glasses 'Specs' for $2,195 Ivanka Trump and Jared Kushner's Albania Resort Plan Sparks Protests and Environmental Concerns 15 Charged in Minnesota for Impeding Federal Agents During Immigration Surge US Education Department's Civil Rights and Special Education Offices to Relocate Mobileye Plans 2027 Robotaxi Service Launch in U.S. City Qualcomm Unveils Snapdragon Reality Elite Chip for Augmented Reality Devices Apple's Future Hardware Rumors: Camera AirPods, Foldable Phones, and New iPhones

CVS Health

Steady2 stories2 sourcesLast updated: 4d ago

Related TopicsAI healthcare Aetna prior authorization interoperability conversational AI pharmacy Google Cloud

Latest Stories

CVS Health leverages AI for personalized care and reduced administrative burdens

4d agoAI summary

CVS Health leverages AI for personalized care and reduced administrative burdens

CVS Health is using AI and real-time data sharing to transform healthcare. Their conversational AI assistant aims to answer questions and guide patients, resolving 75% of pharmacy-related calls. A future AI assistant will proactively manage patient needs using integrated data.

CVS Health to Restore Coverage of Eli Lilly's Weight Loss Drugs

5/28/2026AI summary

CVS Health to Restore Coverage of Eli Lilly's Weight Loss Drugs

CVS Health will restore coverage of Eli Lilly's weight loss injection Zepbound on Oct. 1 and add coverage of its new obesity pill Foundayo on June 1, making both GLP-1 medications co-preferred options on its standard commercial formulary, affecting 25-30 million Americans and boosting Lilly's market position against Novo Nordisk.

CNBC US Markets